Video Experimental Relacionado
Updated: May 10, 2026
06:21
Assessment of the Metabolic Profile of Primary Leukemia Cells
Published on: November 21, 2018
Metabolismo de las células cancerosas: Warburg y más allá
Peggy P Hsu1, David M Sabatini
1Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology Department of Biology, Cambridge, MA 02142, USA.
Cell
|September 9, 2008
Resumen
El efecto Warburg, o glucólisis aeróbica, es un sello distintivo del cáncer. Este ensayo reexamina su papel y proporciona un marco para comprender su contribución al metabolismo de las células cancerosas.
Área de la Ciencia:
- La bioquímica es la bioquímica.
- Oncología Oncología.
- El metabolismo del cáncer.
Sus antecedentes:
- El efecto Warburg, caracterizado por la glucólisis aeróbica, es una alteración metabólica reconocida desde hace mucho tiempo en las células cancerosas.
- A pesar de décadas de estudio, el significado preciso y la contribución del efecto Warburg a la progresión del cáncer siguen siendo incompletamente entendidos.
Objetivo del estudio:
- Examinar de nuevo los principios fundamentales del efecto Warburg.
- Establecer un marco conceptual para comprender el papel del efecto Warburg en la reprogramación metabólica de las células cancerosas.
Principales métodos:
- Revisión de la literatura y síntesis de la investigación existente sobre el metabolismo del cáncer.
- Análisis conceptual y desarrollo del marco teórico.
Principales resultados:
- El efecto Warburg representa una adaptación metabólica significativa crucial para la supervivencia y la proliferación de las células cancerosas.
- Se propone un marco para integrar el efecto Warburg dentro del contexto más amplio del metabolismo de las células cancerosas.
Conclusiones:
- Revisar el efecto Warburg proporciona una visión crítica de las vulnerabilidades metabólicas del cáncer.
- Comprender este sello metabólico es esencial para desarrollar terapias dirigidas contra el cáncer.
Videos de Conceptos Relacionados
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...